12,253
Views
68
CrossRef citations to date
0
Altmetric
Review Articles

Elastases and elastokines: elastin degradation and its significance in health and disease

ORCID Icon
Pages 252-273 | Received 14 Feb 2020, Accepted 08 May 2020, Published online: 12 Jun 2020

References

  • Achyuthan KE, Achyuthan AM. 2001. Comparative enzymology, biochemistry and pathophysiology of human exo-alpha-sialidases (neuraminidases). Comp Biochem Physiol B, Biochem Mol Biol. 129(1):29–64.
  • Akagawa M, Suyama K. 2000. Mechanism of formation of elastin crosslinks. Connect Tissue Res. 41(2):131–141.
  • Alves MF, Puzer L, Cotrin SS, Juliano MA, Juliano L, Bromme D, Carmona AK. 2003. S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates. Biochem J. 373(3):981–986.
  • Antonicelli F, Bellon G, Debelle L, Hornebeck W. 2007. Elastin-elastases and inflamm-aging. Curr Top Dev Biol. 79:99–155.
  • Asagiri M, Takayanagi H. 2007. The molecular understanding of osteoclast differentiation. Bone. 40(2):251–264.
  • Atley LM, Mort JS, Lalumiere M, Eyre DR. 2000. Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope. Bone. 26(3):241–247.
  • Baud S, Duca L, Bochicchio B, Brassart B, Belloy N, Pepe A, Dauchez M, Martiny L, Debelle L. 2013. Elastin peptides in aging and pathological conditions. Biomol Concepts. 4(1):65–76.
  • Bauer CA, Thompson RC, Blout ER. 1976. The active centers of Streptomyces griseus protease 3, alpha-chymotrypsin, and elastase: enzyme-substrate interactions close to the scissile bond. Biochemistry. 15(6):1296–1299.
  • Bax DV, Rodgers UR, Bilek MM, Weiss AS. 2009. Cell adhesion to tropoelastin is mediated via the C-terminal GRKRK motif and integrin alphaVbeta3. J Biol Chem. 284(42):28616–28623.
  • Bhutia YD, Ganapathy V. 2018. Protein digestion and absorption. In: Said HM, editor. Physiology of the gastrointestinal tract. Cambridge, Massachusetts, United States: Academic Press; p. 1063–1086.
  • Bieth JG. 1986. Elastases: catalytic and biological properties. In: Mecham RP, editor. Regulation of matrix accumulation. Orlando, FL: Academic Press, Inc; p. 217–320.
  • Biniossek ML, Nagler DK, Becker-Pauly C, Schilling O. 2011. Proteomic identification of protease cleavage sites characterizes prime and non-prime specificity of cysteine cathepsins B, L, and S. J Proteome Res. 10(12):5363–5373.
  • Bisaccia F, Morelli MA, De Biasi M, Traniello S, Spisani S, Tamburro AM. 1994. Migration of monocytes in the presence of elastolytic fragments of elastin and in synthetic derivates. Structure-activity relationships. Int J Pept Protein Res. 44(4):332–341.
  • Blaise S, Romier B, Kawecki C, Ghirardi M, Rabenoelina F, Baud S, Duca L, Maurice P, Heinz A, Schmelzer CE, et al. 2013. Elastin-derived peptides are new regulators of insulin resistance development in mice. Diabetes. 62(11):3807–3816.
  • Blood CH, Sasse J, Brodt P, Zetter BR. 1988. Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol. 107(5):1987–1993.
  • Blood CH, Zetter BR. 1989. Membrane-bound protein kinase C modulates receptor affinity and chemotactic responsiveness of Lewis lung carcinoma sublines to an elastin-derived peptide. J Biol Chem. 264(18):10614–10620.
  • Boudier C, Holle C, Bieth JG. 1981. Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G. J Biol Chem. 256(20):10256–10258.
  • Brassart B, Fuchs P, Huet E, Alix AJ, Wallach J, Tamburro AM, Delacoux F, Haye B, Emonard H, Hornebeck W, et al. 2001. Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem. 276(7):5222–5227.
  • Braverman IM, Fonferko E. 1982. Studies in cutaneous aging: I. The elastic fiber network. J Invest Dermatol. 78(5):434–443.
  • Bresalier RS, Byrd JC, Wang L, Raz A. 1996. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res. 56(19):4354–4357.
  • Bromme D, Li Z, Barnes M, Mehler E. 1999. Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry. 38(8):2377–2385.
  • Bromme D, Okamoto K, Wang BB, Biroc S. 1996. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem. 271(4):2126–2132.
  • Bromme D, Steinert A, Friebe S, Fittkau S, Wiederanders B, Kirschke H. 1989. The specificity of bovine spleen cathepsin S. A comparison with rat liver cathepsins L and B. Biochem J. 264(2):475–481.
  • Brubaker MJ, Groutas WC, Hoidal JR, Rao NV. 1992. Human neutrophil proteinase 3: mapping of the substrate binding site using peptidyl thiobenzyl esters. Biochem Biophys Res Commun. 188(3):1318–1324.
  • Caenazzo C, Spina M, Onisto M, Fastelli G, Gotte L, Agostini C, Semenzato G, Garbisa S. 1990. Degradation of immobilized soluble elastin by tumor cells in culture: quantitation by ELISA. Int J Cancer. 46(3):552–558.
  • Callahan JW. 1999. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein. Biochim Biophys Acta. 1455(2–3):85–103.
  • Cantarelli B, Duca L, Blanchevoye C, Poitevin S, Martiny L, Debelle L. 2009. Elastin peptides antagonize ceramide-induced apoptosis. FEBS Lett. 583(14):2385–2391.
  • Castiglione Morelli MA, Bisaccia F, Spisani S, De Biasi M, Traniello S, Tamburro AM. 1997. Structure-activity relationships for some elastin-derived peptide chemoattractants. J Pept Res. 49(6):492–499.
  • Choudhury N, Bouchot O, Rouleau L, Tremblay D, Cartier R, Butany J, Mongrain R, Leask RL. 2009. Local mechanical and structural properties of healthy and diseased human ascending aorta tissue. Cardiovasc Pathol. 18(2):83–91.
  • Collins JF, Thoman PJ, Shaw SL, Fine R. 1985. Studies on the elastolytic activity of chymotrypsin. Connect Tissue Res. 13(4):291–298.
  • Coquerel B, Poyer F, Torossian F, Dulong V, Bellon G, Dubus I, Reber A, Vannier JP. 2009. Elastin-derived peptides: matrikines critical for glioblastoma cell aggressiveness in a 3-D system. Glia. 57(16):1716–1726.
  • Cutler RG, Mattson MP. 2001. Sphingomyelin and ceramide as regulators of development and lifespan. Mech Ageing Dev. 122(9):895–908.
  • Davis EC, Mecham RP. 1998. Intracellular trafficking of tropoelastin. Matrix Biol. 17(4):245–254.
  • Debelle L, Tamburro AM. 1999. Elastin: molecular description and function. Int J Biochem Cell Biol. 31(2):261–272.
  • Debret R, Antonicelli F, Theill A, Hornebeck W, Bernard P, Guenounou M, Le Naour R. 2005. Elastin-derived peptides induce a T-helper type 1 polarization of human blood lymphocytes. Arterioscler Thromb Vasc Biol. 25(7):1353–1358.
  • Debret R, Le Naour RR, Sallenave JM, Deshorgue A, Hornebeck WG, Guenounou M, Bernard P, Antonicelli FD. 2006. Elastin fragments induce IL-1beta upregulation via NF-kappaB pathway in melanoma cells. J Invest Dermatol. 126(8):1860–1868.
  • Desforges M, Harris LK, Aplin JD. 2015. Elastin-derived peptides stimulate trophoblast migration and invasion: a positive feedback loop to enhance spiral artery remodelling. Mol Hum Reprod. 21(1):95–104.
  • Donet M, Brassart-Pasco S, Salesse S, Maquart FX, Brassart B. 2014. Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependent mechanism. Br J Cancer. 111(1):139–148.
  • Duca L, Blaise S, Romier B, Laffargue M, Gayral S, El Btaouri H, Kawecki C, Guillot A, Martiny L, Debelle L, et al. 2016. Matrix ageing and vascular impacts: focus on elastin fragmentation. Cardiovasc Res. 110(3):298–308.
  • Duca L, Blanchevoye C, Cantarelli B, Ghoneim C, Dedieu S, Delacoux F, Hornebeck W, Hinek A, Martiny L, Debelle L. 2007. The elastin receptor complex transduces signals through the catalytic activity of its Neu-1 subunit. J Biol Chem. 282(17):12484–12491.
  • Duca L, Debelle L, Debret R, Antonicelli F, Hornebeck W, Haye B. 2002. The elastin peptides-mediated induction of pro-collagenase-1 production by human fibroblasts involves activation of MEK/ERK pathway via PKA- and PI(3)K-dependent signaling. FEBS Lett. 524(1–3):193–198.
  • Duca L, Floquet N, Alix AJ, Haye B, Debelle L. 2004. Elastin as a matrikine. Crit Rev Oncol Hematol. 49(3):235–244.
  • Duca L, Lambert E, Debret R, Rothhut B, Blanchevoye C, Delacoux F, Hornebeck W, Martiny L, Debelle L. 2005. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts. Mol Pharmacol. 67(4):1315–1324.
  • Duffy MJ. 1996. Proteases as prognostic markers in cancer. Clin Cancer Res. 2(4):613–618.
  • Dyksterhuis LB, Baldock C, Lammie D, Wess TJ, Weiss AS. 2007. Domains 17-27 of tropoelastin contain key regions of contact for coacervation and contain an unusual turn-containing crosslinking domain. Matrix Biol. 26(2):125–135.
  • Eckersley A, Ozols M, O’Cualain R, Keevill E-J, Foster A, Pilkington S, Knight D, Griffiths CEM, Watson REB, Sherratt MJ. 2020. Proteomic fingerprints of damage in extracellular matrix assemblies. Matrix Biol Plus. 5:100027.
  • Elkington PT, Friedland JS. 2006. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 61(3):259–266.
  • Eyre DR, Paz MA, Gallop PM. 1984. Cross-linking in collagen and elastin. Annu Rev Biochem. 53:717–748.
  • Fahem A, Robinet A, Cauchard JH, Duca L, Soula-Rothhut M, Rothhut B, Soria C, Guenounou M, Hornebeck W, Bellon G. 2008. Elastokine-mediated up-regulation of MT1-MMP is triggered by nitric oxide in endothelial cells. Int J Biochem Cell Biol. 40(8):1581–1596.
  • Faury G, Garnier S, Weiss AS, Wallach J, Fülöp T, Jacob M-P, Mecham RP, Robert L, Verdetti J. 1998. Action of tropoelastin and synthetic elastin sequences on vascular tone and on free Ca2+ level in human vascular endothelial cells. Circ Res. 82(3):328–226.
  • Faury G, Ristori MT, Verdetti J, Jacob MP, Robert L. 1995. Effect of elastin peptides on vascular tone. J Vasc Res. 32(2):112–119.
  • Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, Singh SK, Boron WF, Hediger MA. 1994. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature. 368(6471):563–566.
  • Floquet N, Hery-Huynh S, Dauchez M, Derreumaux P, Tamburro AM, Alix AJ. 2004. Structural characterization of VGVAPG, an elastin-derived peptide. Biopolymers. 76(3):266–280.
  • Fontana L, Zhao E, Amir M, Dong H, Tanaka K, Czaja MJ. 2013. Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. Hepatology. 57(3):995–1004.
  • Fuchs P, Debelle L, Alix A. 2001. Structural study of some specific elastin hexapeptides activating MMP1. J Mol Struct. 565–566:335–339.
  • Fulop T, Jr., Jacob MP, Khalil A, Wallach J, Robert L. 1998. Biological effects of elastin peptides. Pathol Biol. 46(7):497–506.
  • Gayral S, Garnotel R, Castaing-Berthou A, Blaise S, Fougerat A, Berge E, Montheil A, Malet N, Wymann MP, Maurice P, et al. 2014. Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3Kγ pathway. Cardiovasc Res. 102(1):118–127.
  • Gehrmann M, Briknarova K, Banyai L, Patthy L, Llinas M. 2002. The col-1 module of human matrix metalloproteinase-2 (MMP-2): structural/functional relatedness between gelatin-binding fibronectin type II modules and lysine-binding kringle domains. Biol Chem. 383(1):137–148.
  • Getie M, Schmelzer CEH, Neubert R. 2005b. Characterization of peptides resulting from digestion of human skin elastin with elastase. Proteins. 61(3):649–657.
  • Getie M, Schmelzer CEH, Weiss AS, Neubert R. 2005. Complementary mass spectrometric techniques to achieve complete sequence coverage of recombinant human tropoelastin. Rapid Commun Mass Spectrom. 19(20):2989–2993.
  • Gorisse L, Pietrement C, Vuiblet V, Schmelzer CE, Kohler M, Duca L, Debelle L, Fornes P, Jaisson S, Gillery P. 2016. Protein carbamylation is a hallmark of aging. Proc Natl Acad Sci USA. 113(5):1191–1196.
  • Green EM, Mansfield JC, Bell JS, Winlove CP. 2014. The structure and micromechanics of elastic tissue. Interface Focus. 4(2):20130058.
  • Gronski TJ, Jr., Martin RL, Kobayashi DK, Walsh BC, Holman MC, Huber M, Van Wart HE, Shapiro SD. 1997. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem. 272(18):12189–12194.
  • Grosso LE, Scott M. 1993a. PGAIPG, a repeated hexapeptide of bovine tropoelastin, is a ligand for the 67-kDa bovine elastin receptor. Matrix. 13(2):157–164.
  • Grosso LE, Scott M. 1993b. PGAIPG, a repeated hexapeptide of bovine and human tropoelastin, is chemotactic for neutrophils and Lewis lung carcinoma cells. Arch Biochem Biophys. 305(2):401–404.
  • Groult V, Hornebeck W, Ferrari P, Tixier JM, Robert L, Jacob MP. 1991. Mechanisms of interaction between human skin fibroblasts and elastin: differences between elastin fibres and derived peptides. Cell Biochem Funct. 9(3):171–182.
  • Gunda V, Verma RK, Sudhakar YA. 2013. Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment. Invest Ophthalmol Vis Sci. 54(13):7828–7835.
  • Gupta N, Hixson KK, Culley DE, Smith RD, Pevzner PA. 2010. Analyzing protease specificity and detecting in vivo proteolytic events using tandem mass spectrometry. Proteomics. 10(15):2833–2844.
  • Hance KA, Tataria M, Ziporin SJ, Lee JK, Thompson RW. 2002. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. J Vasc Surg. 35(2):254–261.
  • Hauck M, Seres I, Kiss I, Saulnier J, Mohacsi A, Wallach J, Fulop T. Jr. 1995. Effects of synthesized elastin peptides on human leukocytes. Biochem Mol Biol Int. 37(1):45–55.
  • Heinz A, Jung MC, Duca L, Sippl W, Taddese S, Ihling C, Rusciani A, Jahreis G, Weiss AS, Neubert RHH, et al. 2010. Degradation of tropoelastin by matrix metalloproteinases - cleavage site specificities and release of matrikines. Febs J. 277(8):1939–1956.
  • Heinz A, Jung MC, Jahreis G, Rusciani A, Duca L, Debelle L, Weiss AS, Neubert RHH, Schmelzer C. 2012. The action of neutrophil serine proteases on elastin and its precursor. Biochimie. 94(1):192–202.
  • Heinz A, Schräder CU, Baud S, Keeley FW, Mithieux SM, Weiss AS, Neubert RHH, Schmelzer C. 2014. Molecular-level characterization of elastin-like constructs and human aortic elastin. Matrix Biol. 38:12–21.
  • Heinz A, Taddese S, Sippl W, Neubert RHH, Schmelzer C. 2011. Insights into the degradation of human elastin by matrilysin-1. Biochimie. 93(2):187–194.
  • Hibbert SA, Watson REB, Griffiths CEM, Gibbs NK, Sherratt MJ. 2019. Selective proteolysis by matrix metalloproteinases of photo-oxidised dermal extracellular matrix proteins. Cell Signal. 54:191–199.
  • Hinek A, Jung S, Rutka JT. 1999. Cell surface aggregation of elastin receptor molecules caused by suramin amplified signals leading to proliferation of human glioma cells. Acta Neuropathol. 97(4):399–407.
  • Hinek A, Pshezhetsky AV, von Itzstein M, Starcher B. 2006. Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly. J Biol Chem. 281(6):3698–3710.
  • Hinek A. 1995. The 67 kDa spliced variant of beta-galactosidase serves as a reusable protective chaperone for tropoelastin. Ciba Found Symp. 192:185–196.
  • Hinek A. 1996. Biological roles of the non-integrin elastin/laminin receptor. Biol Chem. 377(7–8):471–480.
  • Hinek A, Rabinovitch M. 1994. 67-kD elastin-binding protein is a protective “companion” of extracellular insoluble elastin and intracellular tropoelastin. J Cell Biol. 126(2):563–574.
  • Hinek A, Rabinovitch M, Keeley F, Okamura-Oho Y, Callahan J. 1993. The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase. J Clin Invest. 91(3):1198–1205.
  • Hinek A, Wrenn DS, Mecham RP, Barondes SH. 1988. The elastin receptor: a galactoside-binding protein. Science. 239(4847):1539–1541.
  • Hofmann UB, Westphal JR, Van Muijen GN, Ruiter DJ. 2000. Matrix metalloproteinases in human melanoma. J Invest Dermatol. 115(3):337–344.
  • Hornebeck W, Adnet JJ, Robert L. 1978. Age dependent variation of elastin and elastase in aorta and human breast cancers. Exp Gerontol. 13(5):293–298.
  • Hornebeck W, Tixier JM, Robert L. 1986. Inducible adhesion of mesenchymal cells to elastic fibers: elastonectin. Proc Natl Acad Sci USA. 83(15):5517–5520.
  • Houghton AM. 2015. Matrix metalloproteinases in destructive lung disease. Matrix Biol 44. 46:167–174.
  • Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD. 2006. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest. 116(3):753–759.
  • Huet E, Brassart B, Cauchard JH, Debelle L, Birembaut P, Wallach J, Emonard H, Polette M, Hornebeck W. 2002. Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells. Clin Exp Metastasis. 19(2):107–117.
  • Huet E, Brassart B, Wallach J, Debelle L, Haye B, Emonard H, Hornebeck W. 2001. [Effect of elastin peptides on the production of matrix metalloproteinase 2 by human skin fibroblasts in culture]. J Soc Biol. 195(2):165–172. French.
  • Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y. 1996. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 56(12):2707–2710.
  • Jacob MP, Hornebeck W. 1985. Isolation and characterization of insoluble and kappa − elastins. Front Matrix Biol. 10:92–129.
  • Jensen SA, Vrhovski B, Weiss AS. 2000. Domain 26 of tropoelastin plays a dominant role in association by coacervation. J Biol Chem. 275(37):28449–28454.
  • Jones PA, DeClerck YA. 1980. Destruction of extracellular matrices containing glycoproteins, elastin, and collagen by metastatic human tumor cells. Cancer Res. 40(9):3222–3227.
  • Joshi R, Heinz A, Fan Q, Guo S, Monia B, Schmelzer CEH, Weiss AS, Batie M, Parameshwaran H, Varisco BM. 2018. Role for cela1 in postnatal lung remodeling and alpha-1 antitrypsin-deficient emphysema. Am J Respir Cell Mol Biol. 59(2):167–178.
  • Jung S, Hinek A, Tsugu A, Hubbard SL, Ackerley C, Becker LE, Rutka JT. 1999. Astrocytoma cell interaction with elastin substrates: implications for astrocytoma invasive potential. Glia. 25(2):179–189.
  • Jung S, Rutka JT, Hinek A. 1998. Tropoelastin and elastin degradation products promote proliferation of human astrocytoma cell lines. J Neuropathol Exp Neurol. 57(5):439–448.
  • Kamoun A, Landeau JM, Godeau G, Wallach J, Duchesnay A, Pellat B, Hornebeck W. 1995. Growth stimulation of human skin fibroblasts by elastin-derived peptides. Cell Adhes Commun. 3(4):273–281.
  • Karnik SK, Wythe JD, Sorensen L, Brooke BS, Urness LD, Li DY. 2003. Elastin induces myofibrillogenesis via a specific domain. VGVAPG Matrix Biol. 22(5):409–425.
  • Katsuda S, Kaji T. 2003. Atherosclerosis and extracellular matrix. J Atheroscler Thromb. 10(5):267–274.
  • Kirschke H, Wiederanders B. 1994. Cathepsin S and related lysosomal endopeptidases. Meth Enzymol. 244:500–511.
  • Koehl C, Knight CG, Bieth JG. 2003. Compared Action of Neutrophil Proteinase 3 and Elastase on Model Substrates. Favorable effect of S’-P’ interactions on proteinase 3 catalysis. J Biol Chem. 278(15):12609–12612.
  • Konigsberg W, Goldstein J, Hill RJ. 1963. The structure of human hemoglobin. VII. The digestion of the beta chain of human hemoglobin with pepsin. J Biol Chem. 238:2028–2033.
  • Korkmaz B, Moreau T, Gauthier F. 2008. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie. 90(2):227–242.
  • Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. 2000. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol. 148(3):615–624.
  • Kozel BA, Wachi H, Davis EC, Mecham RP. 2003. Domains in tropoelastin that mediate elastin deposition in vitro and in vivo. J Biol Chem. 278(20):18491–18498.
  • Lagente V, Le Quement C, Boichot E. 2009. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases. Expert Opin Ther Targets. 13(3):287–295.
  • Lecaille F, Bromme D, Lalmanach G. 2008. Biochemical properties and regulation of cathepsin K activity. Biochimie. 90(2):208–226.
  • Lecaille F, Chowdhury S, Purisima E, Bromme D, Lalmanach G. 2007. The S2 subsites of cathepsins K and L and their contribution to collagen degradation. Protein Sci. 16(4):662–670.
  • Lee P, Bax DV, Bilek MM, Weiss AS. 2014. A novel cell adhesion region in tropoelastin mediates attachment to integrin αVβ5. J Biol Chem. 289(3):1467–1477.
  • Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, et al. 2007. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 13(5):567–569.
  • Loeven WA. 1970. Susceptibility of various kinds of elastin to elastolytic enzymes, trypsin and chymotrypsin. Clin Chim Acta. 27(3):521–533.
  • Loftus IM, Thompson MM. 2002. The role of matrix metalloproteinases in vascular disease. Vasc Med. 7(2):117–133.
  • Long MM, King VJ, Prasad KU, Freeman BA, Urry DW. 1989. Elastin repeat peptides as chemoattractants for bovine aortic endothelial cells. J Cell Physiol. 140(3):512–518.
  • Maeda I, Mizoiri N, Briones MP, Okamoto K. 2007. Induction of macrophage migration through lactose-insensitive receptor by elastin-derived nonapeptides and their analog. J Pept Sci. 13(4):263–268.
  • Magee DF. 1974. Pepsin. Med Clin North Am. 58(6):1277–1287.
  • Maquart FX, Bellon G, Pasco S, Monboisse JC. 2005. Matrikines in the regulation of extracellular matrix degradation. Biochimie. 87(3–4):353–360.
  • Maquart FX, Pasco S, Ramont L, Hornebeck W, Monboisse JC. 2004. An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion. Crit Rev Oncol Hematol. 49(3):199–202.
  • Maquart FX, Simeon A, Pasco S, Monboisse JC. 1999. Regulation of cell activity by the extracellular matrix: the concept of matrikines. J Soc Biol. 193(4–5):423–428.
  • Martin BC, Warram JH, Krolewski AS, Soeldner JS, Kahn CR, Martin BC, Bergman RN. 1992. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 340(8825):925–929.
  • Mason RW, Johnson DA, Barrett AJ, Chapman HA. 1986. Elastinolytic activity of human cathepsin L. Biochem J. 233(3):925–927.
  • Maurice P, Baud S, Bocharova OV, Bocharov EV, Kuznetsov AS, Kawecki C, Bocquet O, Romier B, Gorisse L, Ghirardi M, et al. 2016. New insights into molecular organization of human neuraminidase-1: transmembrane topology and dimerization ability. Sci Rep. 6:38363.
  • Maurice P, Blaise S, Gayral S, Debelle L, Laffargue M, Hornebeck W, Duca L. 2013. Elastin fragmentation and atherosclerosis progression: the elastokine concept. Trends Cardiovasc Med. 23(6):211–221.
  • McLaughlin PJ, Chen Q, Horiguchi M, Starcher BC, Stanton JB, Broekelmann TJ, Marmorstein AD, McKay B, Mecham R, Nakamura T, et al. 2006. Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice. Mol Cell Biol. 26(5):1700–1709.
  • McRae B, Nakajima K, Travis J, Powers JC. 1980. Studies on reactivity of human leukocyte elastase, cathepsin G, and porcine pancreatic elastase toward peptides including sequences related to the reactive site of alpha 1-protease inhibitor (alpha 1-antitrypsin). Biochemistry. 19(17):3973–3978.
  • Mecham RP, Broekelmann TJ, Fliszar CJ, Shapiro SD, Welgus HG, Senior RM. 1997. Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J Biol Chem. 272(29):18071–18076.
  • Mecham RP, Hinek A, Entwistle R, Wrenn DS, Griffin GL, Senior RM. 1989. Elastin binds to a multifunctional 67-kilodalton peripheral membrane protein. Biochemistry. 28(9):3716–3722.
  • Miekus N, Luise C, Sippl W, Baczek T, Schmelzer CEH, Heinz A. 2019. MMP-14 degrades tropoelastin and elastin. Biochimie. 165:32–39.
  • Mithieux SM, Weiss AS. 2005. Elastin. Adv Protein Chem. 70:437–461.
  • Mochizuki S, Brassart B, Hinek A. 2002. Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem. 277(47):44854–44863.
  • Mora Huertas AC, Schmelzer CEH, Hoehenwarter W, Heyroth F, Heinz A. 2016. Molecular-level insights into aging processes of skin elastin. Biochimie. 128–129:163–173.
  • Mora Huertas AC, Schmelzer CEH, Luise C, Sippl W, Pietzsch M, Hoehenwarter W, Heinz A. 2018. Degradation of tropoelastin and skin elastin by neprilysin. Biochimie. 146:73–78.
  • Morisaki N, Moriwaki S, Sugiyama-Nakagiri Y, Haketa K, Takema Y, Imokawa G. 2010. Neprilysin is identical to skin fibroblast elastase: its role in skin aging and UV responses. J Biol Chem. 285(51):39819–39827.
  • Moroy G, Alix AJP, Hery-Huynh S. 2005. Structural characterization of human elastin derived peptides containing the GXXP sequence. Biopolymers. 78(4):206–220.
  • Mort JS, Buttle DJ. 1997. Cathepsin B. Int J Biochem Cell Biol. 29(5):715–720.
  • Muiznieks LD, Sharpe S, Pomes R, Keeley FW. 2018. Role of liquid-liquid phase separation in assembly of elastin and other extracellular matrix proteins. J Mol Biol. 430(23):4741–4753.
  • Nackman GB, Karkowski FJ, Halpern VJ, Gaetz HP, Tilson MD. 1996. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. Ann N Y Acad Sci. 800:260–262.
  • Nackman GB, Karkowski FJ, Halpern VJ, Gaetz HP, Tilson MD. 1997. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. Surgery. 122(1):39–44.
  • Nagase H, Fields GB. 1996. Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. Biopolymers. 40(4):399–416.
  • Nagase H, Woessner JF. Jr. 1999. Matrix metalloproteinases. J Biol Chem. 274(31):21491–21494.
  • Nakajima H, Ezaki Y, Nagai T, Yoshioka R, Imokawa G. 2012. Epithelial-mesenchymal interaction during UVB-induced up-regulation of neutral endopeptidase. Biochem J. 443(1):297–305.
  • Nakamura T. 2018. Roles of short fibulins, a family of matricellular proteins, in lung matrix assembly and disease. Matrix Biol. 73:21–33.
  • Naylor EC, Watson RE, Sherratt MJ. 2011. Molecular aspects of skin ageing. Maturitas. 69(3):249–256.
  • Netzel-Arnett S, Sang QX, Moore WG, Navre M, Birkedal-Hansen H, Van Wart HE. 1993. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry. 32(25):6427–6432.
  • Novinec M, Grass RN, Stark WJ, Turk V, Baici A, Lenarcic B. 2007. Interaction between human cathepsins K, L, and S and elastins: mechanism of elastinolysis and inhibition by macromolecular inhibitors. J Biol Chem. 282(11):7893–7902.
  • Ntayi C, Labrousse AL, Debret R, Birembaut P, Bellon G, Antonicelli F, Hornebeck W, Bernard P. 2004. Elastin-derived peptides upregulate matrix metalloproteinase-2-mediated melanoma cell invasion through elastin-binding protein. J Invest Dermatol. 122(2):256–265.
  • O’Rourke MF. 2007. Arterial aging: pathophysiological principles. Vasc Med. 12(4):329–341.
  • Oefner C, D’Arcy A, Hennig M, Winkler FK, Dale GE. 2000. Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon. J Mol Biol. 296(2):341–349.
  • Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 272(4):2446–2451.
  • Owen CA, Campbell EJ. 1999. The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol. 65(2):137–150.
  • Pandey KC, De S, Mishra PK. 2017. Role of proteases in chronic obstructive pulmonary disease. Front Pharmacol. 8:512.
  • Panwar P, Hedtke T, Heinz A, Andrault PM, Hoehenwarter W, Granville DJ, Schmelzer CEH, Bromme D. 2020. Expression of elastolytic cathepsins in human skin and their involvement in age-dependent elastin degradation. Biochim Biophys Acta Gen Subj. 1864(5):129544.
  • Parks WC, Pierce RA, Lee KA, Mecham RP. 1993. Elastin. In: Kleinman HK, editor. Advances in Molecular and Cell Biology. Greenwich, CT: JAI Press. p. 133–182.
  • Partridge SM, Davis HF, Adair GS. 1955. The chemistry of connective tissues. 2. Soluble proteins derived from partial hydrolysis of f elastin. Biochem J. 61(1):11–21.
  • Paul RG, Bailey AJ. 1996. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol. 28(12):1297–1310.
  • Pauletti GM, Okumu FW, Borchardt RT. 1997. Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway. Pharm Res. 14(2):164–168.
  • Perng DW, Chen PK. 2017. The relationship between airway inflammation and exacerbation in chronic obstructive pulmonary disease. Tuberc Respir Dis. 80(4):325–335.
  • Petersen E, Wagberg F, Angquist KA. 2002. Serum concentrations of elastin-derived peptides in patients with specific manifestations of atherosclerotic disease. Eur J Vasc Endovasc Surg. 24(5):440–444.
  • Peterszegi G, Robert AM, Robert L. 1996. Presence of the elastin-laminin receptor on human activated lymphocytes. C R Acad Sci III. 319(9):799–803.
  • Peterszegi G, Robert L. 1998. Cell death induced in lymphocytes expressing the elastin-laminin receptor by excess agonists: necrosis and apoptosis. Biomed Pharmacother. 52(9):369–377.
  • Peterszegi G, Texier S, Robert L. 1999. Cell death by overload of the elastin-laminin receptor on human activated lymphocytes: protection by lactose and melibiose. Eur J Clin Invest. 29(2):166–172.
  • Phinikaridou A, Lacerda S, Lavin B, Andia ME, Smith A, Saha P, Botnar RM. 2018. Tropoelastin: a novel marker for plaque progression and instability. Circ Cardiovasc Imaging. 11(8):e007303.
  • Pocza P, Süli-Vargha H, Darvas Z, Falus A. 2008. Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. Int J Cancer. 122(9):1972–1980.
  • Polanowska J, Krokoszynska I, Czapinska H, Watorek W, Dadlez M, Otlewski J. 1998. Specificity of human cathepsin G. Biochim Biophys Acta. 1386(1):189–198.
  • Powell JT, Vine N, Crossman M. 1992. On the accumulation of D-aspartate in elastin and other proteins of the ageing aorta. Atherosclerosis. 97(2–3):201–208.
  • Powers JC, Gupton BF, Harley AD, Nishino N, Whitley RJ. 1977. Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones. Biochim Biophys Acta. 485(1):156–166.
  • Privitera S, Prody CA, Callahan JW, Hinek A. 1998. The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein. J Biol Chem. 273(11):6319–6326.
  • Proudfoot D, Shanahan CM. 2001. Biology of calcification in vascular cells: intima versus media. Herz. 26(4):245–251.
  • Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, Weiss SJ. 2000. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med. 192(6):789–799.
  • Rabkin SW. 2017. The role matrix metalloproteinases in the production of aortic aneurysm. Prog Mol Biol Transl Sci. 147:239–265.
  • Rao NV, Wehner NG, Marshall BC, Gray WR, Gray BH, Hoidal JR. 1991. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem. 266(15):9540–9548.
  • Robert L, Robert AM, Fulop T. 2008. Rapid increase in human life expectancy: will it soon be limited by the aging of elastin? Biogerontology. 9(2):119–133.
  • Robinet A, Fahem A, Cauchard JH, Huet E, Vincent L, Lorimier S, Antonicelli F, Soria C, Crepin M, Hornebeck W, et al. 2005. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci. 118(2):343–356.
  • Rodgers UR, Weiss AS. 2005. Cellular interactions with elastin. Pathol Biol. 53(7):390–398.
  • Romier B, Ivaldi C, Sartelet H, Heinz A, Schmelzer CEH, Garnotel R, Guillot A, Jonquet J, Bertin E, Gueant JL, et al. 2018. Production of elastin-derived peptides contributes to the development of nonalcoholic steatohepatitis. Diabetes. 67(8):1604–1615.
  • Rusciani A, Duca L, Sartelet H, Chatron-Colliet A, Bobichon H, Ploton D, Le Naour R, Blaise S, Martiny L, Debelle L. 2010. Elastin peptides signaling relies on neuraminidase-1-dependent lactosylceramide generation. PloS One. 5(11):e14010.
  • Satake M, Enjoh M, Nakamura Y, Takano T, Kawamura Y, Arai S, Shimizu M. 2002. Transepithelial transport of the bioactive tripeptide, val-pro-pro, in human intestinal Caco-2 cell monolayers. Biosci Biotechnol Biochem. 66(2):378–384.
  • Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370(6484):61–65.
  • Sbardella D, Fasciglione GF, Gioia M, Ciaccio C, Tundo GR, Marini S, Coletta M. 2012. Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Aspects Med. 33(2):119–208.
  • Schmelzer CEH, Getie M, Neubert R. 2005. Mass spectrometric characterization of human skin elastin peptides produced by proteolytic digestion with pepsin and thermitase. J Chromatogr A. 1083(1–2):120–126.
  • Schmelzer CEH, Jung MC, Wohlrab J, Neubert RHH, Heinz A. 2012. Does human leukocyte elastase degrade intact skin elastin? Febs J. 279(22):4191–4200.
  • Schmelzer CEH, Schops R, Reynell L, Ulbrich-Hofmann R, Neubert RHH, Raith K. 2007. Peptic digestion of beta-casein. Time course and fate of possible bioactive peptides. J Chromatogr A. 1166(1–2):108–115.
  • Seiki M, Yana I. 2003. Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci. 94(7):569–574.
  • Senior RM, Griffin GL, Mecham RP. 1980. Chemotactic activity of elastin-derived peptides. J Clin Invest. 66(4):859–862.
  • Senior RM, Griffin GL, Mecham RP. 1982. Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest. 70(3):614–618.
  • Senior RM, Griffin GL, Mecham RP, Wrenn DS, Prasad KU, Urry DW. 1984. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol. 99(3):870–874.
  • Sexton T, Hitchcook LJ, Rodgers DW, Bradley LH, Hersh LB. 2012. Active site mutations change the cleavage specificity of neprilysin. PloS One. 7(2):e32343.
  • Shapiro SD, Endicott SK, Province MA, Pierce JA, Campbell EJ. 1991. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon. J Clin Invest. 87(5):1828–1834.
  • Shiratsuchi E, Ura M, Nakaba M, Maeda I, Okamoto K. 2010. Elastin peptides prepared from piscine and mammalian elastic tissues inhibit collagen-induced platelet aggregation and stimulate migration and proliferation of human skin fibroblasts. J Pept Sci. 16(11):652–658.
  • Simionescu A, Philips K, Vyavahare N. 2005. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun. 334(2):524–532.
  • Sivan SS, Van El B, Merkher Y, Schmelzer CEH, Zuurmond AM, Heinz A, Wachtel E, Varga PP, Lazary A, Brayda-Bruno M, et al. 2012. Longevity of elastin in human intervertebral disc as probed by the racemization of aspartic acid. Biochim Biophys Acta. 1820(10):1671–1677.
  • Spezzacatena C, Pepe A, Green LM, Sandberg LB, Bochicchio B, Tamburro AM. 2005. Synthesis, solution structure and biological activity of Val-Val-Pro-Gln, a bioactive elastin peptide. Eur J Org Chem. 2005(8):1644–1651.
  • Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 17:463–516.
  • Svitkina TM, Parsons DF. 1993. Binding of some metastatic tumor cell lines to fibrous elastin and elastin peptides. Int J Cancer. 53(5):824–828.
  • Szendroi M, Meimon G, Bakala H, Frances C, Robert L, Godeau G, Hornebeck W. 1984. On the presence of a metalloprotease in human skin fibroblasts that degrades the human skin elastic fiber system. J Invest Dermatol. 83(3):224–229.
  • Szychowski KA, Rombel-Bryzek A, Dołhańczuk-Śródka A, Gmiński J. 2019. Antiproliferative effect of elastin-derived peptide VGVAPG on SH-SY5Y neuroblastoma cells. Neurotox Res. 36(3):503–514.
  • Szychowski KA, Wójtowicz AK, Gmiński J. 2019. Impact of elastin-derived peptide VGVAPG on matrix metalloprotease-2 and -9 and the tissue inhibitor of metalloproteinase-1, -2, -3 and -4 mRNA expression in mouse cortical glial cells in vitro. Neurotox Res. 35(1):100–110.
  • Taddese S, Weiss AS, Neubert RHH, Schmelzer CEH. 2008. Mapping of macrophage elastase cleavage sites in insoluble human skin elastin. Matrix Biol. 27(5):420–428.
  • Taddese S, Weiss AS, Jahreis G, Neubert RH, Schmelzer CEH. 2009. In vitro degradation of human tropoelastin by MMP-12 and the generation of matrikines from domain 24. Matrix Biol. 28(2):84–91.
  • Tajima S, Wachi H, Uemura Y, Okamoto K. 1997. Modulation by elastin peptide VGVAPG of cell proliferation and elastin expression in human skin fibroblasts. Arch Dermatol Res. 289(8):489–492.
  • Talukdar S, Oh DY, Bandyopadhyay G, Li D, Xu J, McNelis J, Lu M, Li P, Yan Q, Zhu Y, et al. 2012. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med. 18(9):1407–1412.
  • Tetley TD. 2002. Macrophages and the pathogenesis of COPD. Chest. 121(5):156S–159S.
  • Thomson J, Singh M, Eckersley A, Cain SA, Sherratt MJ, Baldock C. 2019. Fibrillin microfibrils and elastic fibre proteins: functional interactions and extracellular regulation of growth factors. Semin Cell Dev Biol. 89:109–117.
  • Timar J, Lapis K, Fulop T, Varga ZS, Tixier JM, Robert L, Hornebeck W. 1991. Interaction between elastin and tumor cell lines with different metastatic potential; in vitro and in vivo studies. J Cancer Res Clin Oncol. 117(3):232–238.
  • Tiraboschi G, Jullian N, Thery V, Antonczak S, Fournie-Zaluski MC, Roques BP. 1999. A three-dimensional construction of the active site (region 507-749) of human neutral endopeptidase (EC.3.4.24.11). Protein Eng. 12(2):141–149.
  • Tolosa E, Li W, Yasuda Y, Wienhold W, Denzin LK, Lautwein A, Driessen C, Schnorrer P, Weber E, Stevanovic S, et al. 2003. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J Clin Invest. 112(4):517–526.
  • Toupance S, Brassart B, Rabenoelina F, Ghoneim C, Vallar L, Polette M, Debelle L, Birembaut P. 2012. Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA. Clin Exp Metastasis. 29(5):511–522.
  • Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, Turk D. 2012. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim Biophys Acta. 1824(1):68–88.
  • Uemura Y, Okamoto K. 1997. Elastin-derived peptide induces monocyte chemotaxis by increasing intracellular cyclic GMP level and activating cyclic GMP dependent protein kinase. Biochem Mol Biol Int. 41(1):57–64.
  • Van Doren SR. 2015. Matrix metalloproteinase interactions with collagen and elastin. Matrix Biol. 44-46:224–231.
  • Vierkötter A, Krutmann J. 2012. Environmental influences on skin aging and ethnic-specific manifestations. Dermatoendocrinol. 4(3):227–231.
  • Vig BS, Stouch TR, Timoszyk JK, Quan Y, Wall DA, Smith RL, Faria TN. 2006. Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding. J Med Chem. 49(12):3636–3644.
  • Visse R, Nagase H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 92(8):827–839.
  • Vrhovski B, Weiss AS. 1998. Biochemistry of tropoelastin. Eur J Biochem. 258(1):1–18.
  • Wachi H, Seyama Y, Yamashita S, Suganami H, Uemura Y, Okamoto K, Yamada H, Tajima S. 1995. Stimulation of cell proliferation and autoregulation of elastin expression by elastin peptide VPGVG in cultured chick vascular smooth muscle cells. FEBS Lett. 368(2):215–219.
  • Wahart A, Hocine T, Albrecht C, Henry A, Sarazin T, Martiny L, El Btaouri H, Maurice P, Bennasroune A, Romier-Crouzet B, et al. 2019. Role of elastin peptides and elastin receptor complex in metabolic and cardiovascular diseases. Febs J. 286(15):2980–2993.
  • Wang B, Shi GP, Yao PM, Li Z, Chapman HA, Bromme D. 1998. Human cathepsin F. Molecular cloning, functional expression, tissue localization, and enzymatic characterization. J Biol Chem. 273(48):32000–32008.
  • Wang B, Sun J, Kitamoto S, Yang M, Grubb A, Chapman HA, Kalluri R, Shi GP. 2006. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem. 281(9):6020–6029.
  • Watanabe M, Sawai T, Nagura H, Suyama K. 1996. Age-related alteration of cross-linking amino acids of elastin in human aorta. Tohoku J Exp Med. 180(2):115–130.
  • Werb Z, Banda MJ, McKerrow JH, Sandhaus RA. 1982. Elastases and elastin degradation. J Invest Dermatol. 79(1):154s–159s.
  • Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. 1996. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem. 271(29):17119–17123.
  • Yamamoto M, Akazawa K, Aoyagi M, Yamamoto N, Yamamoto K. 2002. Changes in elastin-binding protein in fibroblasts derived from cardinal ligaments of patients with prolapsus uteri. Cell Biol Int. 26(5):441–449.
  • Yanagisawa H, Davis EC. 2010. Unraveling the mechanism of elastic fiber assembly: the roles of short fibulins. Int J Biochem Cell Biol. 42(7):1084–1093.
  • Yang M, Zhang Y, Pan J, Sun J, Liu J, Libby P, Sukhova GK, Doria A, Katunuma N, Peroni OD, et al. 2007. Cathepsin L activity controls adipogenesis and glucose tolerance. Nat Cell Biol. 9(8):970–977.
  • Yasuda Y, Li Z, Greenbaum D, Bogyo M, Weber E, Bromme D. 2004. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J Biol Chem. 279(35):36761–36770.